User profiles for Nurettin Erben

Nurettin Erben

Eskisehir Osmangazi University, Faculty of Medicine
Verified email at ogu.edu.tr
Cited by 4342

Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study

…, G Desoubeaux, L Drgona, N Erben… - The Lancet Infectious …, 2023 - thelancet.com
Background The European Confederation of Medical Mycology (ECMM) collected data on
epidemiology, risk factors, treatment, and outcomes of patients with culture-proven …

Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry

…, E De Kort, L Verga, L Serrano, N Erben… - …, 2023 - thelancet.com
Background Nirmatrelvir/ritonavir treatment decreases the hospitalisation rate in
immunocompetent patients with COVID-19, but data on efficacy in patients with haematological …

International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003–2012

H Leblebicioglu, N Erben, VD Rosenthal… - Annals of clinical …, 2014 - Springer
Background Device-associated healthcare-acquired infections (DA-HAI) pose a threat to
patient safety, particularly in the intensive care unit (ICU). We report the results of the …

International Nosocomial Infection Control Consortium (INICC) report, data summary of 45 countries for 2013-2018, adult and pediatric units, device-associated …

…, V Baytas, R Tekin, AN Yalçın, N Erben - American journal of …, 2021 - Elsevier
Background We report the results of INICC surveillance study from 2013 to 2018, in 664
intensive care units (ICUs) in 133 cities, of 45 countries, from Latin-America, Europe, Africa, …

Temporal trends in the epidemiology of HIV in Turkey

…, A Deveci, MK Celen, S Kose, N Erben… - Current HIV …, 2020 - ingentaconnect.com
Objective: The aim of this study was to analyze the temporal trends of HIV epidemiology in
Turkey from 2011 to 2016. Methods: Thirty-four teams from 28 centers at 17 different cities …

[HTML][HTML] Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

…, MV Papa, A Yahya, A Aujayeb, J Novák, N Erben… - …, 2024 - thelancet.com
Background The COVID-19 pandemic heightened risks for individuals with hematological
malignancies due to compromised immune systems, leading to more severe outcomes and …

Time-dependent analysis of extra length of stay and mortality due to ventilator-associated pneumonia in intensive-care units of ten limited-resources countries …

…, FE Udwadia, HJ Munoz, N Erben… - Epidemiology & …, 2011 - cambridge.org
Ventilator-associated pneumonias (VAPs) are a worldwide problem that significantly increases
patient morbidity, mortality, and length of stay (LoS), and their effects should be estimated …

Comparison of non-invasive fibrosis markers and classical liver biopsy in chronic hepatitis C

G Usluer, N Erben, N Aykin, O Dagli, O Aydogdu… - European journal of …, 2012 - Springer
The aim of this study was to compare the results of nine non-invasive serum biomarkers with
liver biopsies to predict liver fibrosis stage. HCV-RNA-positive, HCV genotype 1, treatment-…

Surgical site infection rates in 16 cities in Turkey: findings of the International Nosocomial Infection Control Consortium (INICC)

H Leblebicioglu, N Erben, VD Rosenthal… - American journal of …, 2015 - Elsevier
… Author links open overlay panel Hakan Leblebicioglu MD a , Nurettin Erben MD b , Victor
D. Rosenthal MD, MSc, CIC c , Alper Sener MD d , Cengiz Uzun MD e , Gunes Senol MD f , …

[PDF][PDF] The prevalence of extended-spectrum beta lactamase-producing Escherichia coli and Klebsiella pneumoniae in clinical isolates and risk factors

I Ozgunes, N Erben, A Kiremitci, ED Kartal… - Saudi medical …, 2006 - researchgate.net
… Ilhan Ozgunes, MD, Nurettin Erben, MD, Abdurahman Kiremitci, MD, Elif D. Kartal, MD,
Gul Durmaz, MD, Hasan Colak, MD, Gaye Usluer, MD, Ertugrul Colak, MSc. … From the …